{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:50:10Z","timestamp":1762429810400},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":6428,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1254\/jjp.90.131","type":"journal-article","created":{"date-parts":[[2002,10,21]],"date-time":"2002-10-21T01:50:49Z","timestamp":1035165049000},"page":"131-137","source":"Crossref","is-referenced-by-count":13,"title":["Effects of KMD-3213, a Uroselective \u03b11A-Adrenoceptor Antagonist, on the Tilt-Induced Blood Pressure Response in Normotensive Rats"],"prefix":"10.1016","volume":"90","author":[{"given":"Katsuyoshi","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masachiyo","family":"Hora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makio","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.90.131_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0160-5402(82)90055-9","article-title":"A rat model for predicting ortho-static hypertension during acute and chronic antihypertensive drug therapy","volume":"7","author":"Humphrey","year":"1982","journal-title":"J Pharmacol Methods"},{"key":"10.1254\/jjp.90.131_bib2","first-page":"267","article-title":"International Union of Pharmacology, X. Recommendation for nomenclature of ai-adrenoceptors: consensus update","volume":"47","author":"Hieble","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1254\/jjp.90.131_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-5347(17)35544-1","article-title":"Identification, quantification, and localization of mRNA for three distinct a1-adrenergic receptor subtypes in human prostate","volume":"150","author":"Price","year":"1993","journal-title":"J Urol"},{"key":"10.1254\/jjp.90.131_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02409016","article-title":"Detection of a1-adreno-ceptor subtypes in human hypertrophied prostate by in situ hybridization","volume":"28","author":"Moriyama","year":"1996","journal-title":"Histochem J"},{"key":"10.1254\/jjp.90.131_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1996.tb15742.x","article-title":"Quantification and distribution of a1-adrenoceptor subtype mRNAs in human prostate: Comparison of benign hypertrophied tissue and non-hypertrophied tissue","volume":"119","author":"Nasu","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1476-5381.1995.tb15001.x","article-title":"Noradrenaline contractions of human prostate mediated by a ia- (a ic-) adrenoceptor subtype","volume":"115","author":"Marshall","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1994.tb17053.x","article-title":"Pharmacological evidence of distinct a 1-adreno-ceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery","volume":"113","author":"Hatano","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-5347(05)67426-5","article-title":"Tissue selectivity of KMD-3213, an a 1-adreno-ceptor antagonist, in human prostate and vasculature","volume":"164","author":"Murata","year":"2000","journal-title":"J Urol"},{"key":"10.1254\/jjp.90.131_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1254\/jjp.78.331","article-title":"Tamsulosin: ai-adrenoceptor subtype-selectivity and comparison with terazosin","volume":"78","author":"Muramatsu","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib10","first-page":"147","article-title":"Effect of tamsulosin, a novel ai-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs","volume":"16","author":"Sudoh","year":"1996","journal-title":"J Auton Pharmacol"},{"key":"10.1254\/jjp.90.131_bib11","first-page":"250","article-title":"KMD-3213, a novel, potent, a 1a-adreno-ceptor-selective antagonist: characterization using recombinant human a ^adrenoceptors and native tissues","volume":"48","author":"Shibata","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.90.131_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bjp.0702489","article-title":"Pharmacological analysis of the novel, selective a \u00ed-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand","volume":"127","author":"Murata","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(96)00589-4","article-title":"Effect of KMD-3213, an a ia-adrenoceptor-selec-tive antagonist, on the contraction of rabbit prostate and rabbit and rat aorta","volume":"315","author":"Yamagishi","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib14","first-page":"81","article-title":"KMD-3213, a uroselective and long-acting a^-adrenoceptor antagonist, tested in a novel rat model","volume":"291","author":"Akiyama","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.90.131_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01009-1","article-title":"KMD-3213, novel a1A-adreno-ceptor antagonist, potently inhibits the functional ai-adreno-ceptor in human prostate","volume":"331","author":"Moriyama","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0160-5402(82)90055-9","article-title":"A rat model for predicting ortho-static hypotension during acute and chronic antihypertensive drug therapy","volume":"7","author":"Humphrey","year":"1982","journal-title":"J Pharmacol Methods"},{"key":"10.1254\/jjp.90.131_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0700907","article-title":"The effects of tamsulosin, a higher affinity antagonist at functional a 1A- and a 1D-adrenoceptor subtype","volume":"120","author":"Noble","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.90.131_bib18","first-page":"2503","article-title":"Phase I clinical trial of YM617, a new a 1 adrenoceptor antagonist - First Report: a single oral dose of conventional formulation in healthy male subjects -","volume":"12","author":"Tsunoo","year":"1990","journal-title":"Rinshoiyaku"},{"key":"10.1254\/jjp.90.131_bib19","first-page":"2529","article-title":"Phase I clinical trial of YM617, a new a 1 adrenoceptor antagonist - Second Report: a single oral dose of controlled release formulation in healthy male subjects -","volume":"12","author":"Tsunoo","year":"1990","journal-title":"Rinshoiyaku"},{"key":"10.1254\/jjp.90.131_bib20","first-page":"145","article-title":"Tamsulosin, the first prostate selective a 1a-adrenoceptor antagonist","volume":"29","author":"Schulrman","year":"1996","journal-title":"Eur Urol"},{"key":"10.1254\/jjp.90.131_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0090-4295(98)00140-X","article-title":"Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenocptor antagonist","volume":"51","author":"Beduchi","year":"1998","journal-title":"Urology"},{"key":"10.1254\/jjp.90.131_bib22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(98)00126-5","article-title":"Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia","volume":"51","author":"Lepor","year":"1998","journal-title":"Urology"},{"key":"10.1254\/jjp.90.131_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0090-4295(98)00127-7","article-title":"Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled double-blind extension of phase III trial","volume":"51","author":"Lepor","year":"1998","journal-title":"Urology"},{"key":"10.1254\/jjp.90.131_bib24","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0024-3205(98)00111-8","article-title":"In vivo receptor binding of novel a1-adrenoceptor antagonists for the treatment ofbenign prostatic hyperplasia","volume":"62","author":"Yamada","year":"1998","journal-title":"Life Science"},{"key":"10.1254\/jjp.90.131_bib25","first-page":"160","article-title":"In vivo demonstration of a 1A-adrenoceptor subtype selectivity of KMD-3213 in rat tissue","volume":"296","author":"Yamada","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.90.131_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1442-2042.2001.00277.x","article-title":"Effect ofKMD-3213, an a 1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs","volume":"8","author":"Akiyama","year":"2001","journal-title":"Int J Urol"},{"key":"10.1254\/jjp.90.131_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000056163","article-title":"Relationship between prostatic a1-adrenoceptor nding and reduction in intra-urethral pressure following continuous infusion of KMD-3213 in rats","volume":"64","author":"Akiyama","year":"2002","journal-title":"Pharmacology"},{"key":"10.1254\/jjp.90.131_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1254\/jjp.77.61","article-title":"Vascular a1-adrenoceptor subtype selectivity and a1-blocker induced orthostatic hypotension","volume":"77","author":"Take","year":"1998","journal-title":"Jpn J Pharmacol"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819300460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819300460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jjp\/90\/2\/90_2_131\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:00:14Z","timestamp":1605636014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819300460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002]]}},"alternative-id":["S0021519819300460"],"URL":"https:\/\/doi.org\/10.1254\/jjp.90.131","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}